However, combination of docetaxel with hypo-fractionated RT particularly renders HPV-positive HNSCC tumor cells more immunogenic, characterized by increased release of HMGB1 and increased expression of immune stimulatory checkpoint molecules, with hypo-fractionated RT being the main trigger for it. This evidence concerns the gene HMGB1 and head and neck squamous cell carcinoma.